Bone marrow is like the offensive line of the immune system — it’s an essential part of the team but doesn’t always gets the recognition. By pumping out hundreds of billions of blood cells every day, bone marrow helps us fend off disease and is essential to a healthy human body.
To better understand how marrow fortifies us against disease — and to potentially help develop better therapies for diseases like leukemia — researchers have sought to develop artificial bone marrow that functions like the real thing. The problem is, living blood cells reside and multiply in a special environment, called the hematopoietic niche, which scientists have so far failed to replicate.
But now, researchers from the University of Basel and ETH Zurich have engineered an artificial bone marrow that mimics the natural kinds, offering a key to better understand how blood forms and how blood diseases can be treated.
“This 3D engineered tissue is established and maintained in a bioreactor system,” Ivan Martin, a professor of biomedicine at the University of Basel who worked on the project, told Digital Trends. “It partially recapitulates the structure, composition, and organization of the native bone marrow microenvironment … but also its main function, which is the replication and differentiation in more mature cells.”
Martin and his colleagues used a ceramic bonelike scaffold, which they combined with living cells in a bioreactor, mixing the synthetic and organic components together.
Within that artificial system, cells are able to multiply over the course of several days — not as long as natural bone marrow, but degrees better than previous synthetic models. Rather than immediate medical applications, the researchers hope their technique leads to more sophisticated, tailor-made marrow models, which can assist in drug screening.
“More than a direct medical demand, the fields of hematology and tissue engineering lacked a model close enough to sustain reasonable comparison with the in vivo human bone marrow microenvironment,” Matin said. “Indeed, research has limited possibilities to access information from human specimens and the human hematopoietic niche has remained rather inaccessible to experimental manipulation and optical observation.”
Moving forward, Martin and his team hope to use this system to study blood disorders, particularly the conditions within which these conditions first arise.
A paper detailing their research was published this week in the journal Proceeding of the National Academy of Sciences.
Google has been finding more ways to make Gemini a part of your daily routine, from putting together playlists to ordering groceries through your favorite apps. Now it's expanding those capabilities to more services, with Google Search joining in, too.
The company has announced a new Connected Apps Platform that makes it easier for developers to bring their services to both Gemini and Search. Alongside this, Google is adding new partners to its growing lineup, bringing more of the apps people already use into its AI ecosystem.
In the broad context of AI and its perceived harms, health and medical risks often pop up in the conversation. The warnings even come from frontier AI labs, such as ChatGPT-maker OpenAI and Anthropic, both of which have warned about misusing AI to cook up bioweapons. Security experts have already spotted a few such incidents in the wild, especially with the usage of AI models without any solid guardrails.
Well, it appears that the risks run deeper. As per an analysis appearing in the British Medical Journal (BMJ), AI bots are now being deployed to influence public policies governing health risks to citizens. In this instance, an attempt was made using AI bots to thwart regulations that aim to restrict the sale of disposable vapes, all while disguising the manipulation efforts as a response from real humans.
What if checking your drinking water for dangerous chemicals were as simple as plugging a tiny gadget into your smartphone? Researchers in Japan have developed a compact sensor that could make that possible, potentially bringing sophisticated water contamination testing out of expensive laboratories and into people's hands.
Scientists at the Okinawa Institute of Science and Technology (OIST) have created a portable device capable of detecting extremely low concentrations of PFAS, commonly known as "forever chemicals." The findings were published in the journal Biosensors and Bioelectronics, which demonstrate how an inexpensive sensor and a smartphone could make identifying potentially harmful chemicals in water a lot easier.